107.00p-0.50 (-0.47%)15 Nov 2024, 16:54
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.AJ Bell logo

Epwin Group PLC Shares News & Articles

Big returns from small caps: How the experts find the stars of the future and our three best ideas

Over the long haul, small-caps have historically outperformed large caps, fuelling the research highlighting the so-called 'small-cap effect' ? the idea that smaller companies offer higher risk-adjusted returns than larger ones. Unfortunately, the higher interest rate environment of recent years has proved tough for the stock market's small fry, who've spent more than a decade lagging more sizeabl

FTSE 100 hangs on above 7,000 to close in the green while US mixed ahead of latest US Fed update

The UK's index of blue-chip shares finished the day holding in the green up 0.3% to close at 7,016.63.Across the pond, US markets were mixed as investors await update from US Federal Reserve, with tech and small caps rebounding. The Dow and S&P 500 were both trading modestly in the red but the Nasdaq Composite and Russell 2000 rallied 0.4% and 1% respectively.As well as continuing concerns about i

UK equities close higher on Brexit/US stimulus hopes; gadgets boost Dixons profits

UK markets held on to gains throughout Wednesday to end the session higher as investors cling to hopes of a stimulus package being agreed by US lawmakers and that UK and EU negotiators can pull a last-ditch trade agreement out of the fire.The UK's post-Brexit trade deal transition period ends on 1 January 2021.Meaningful progress on either the stimulus or Brexit fronts could help markets rally in

FTSE firms on US stimulus hopes, Dixons Carphone rallies on first half profit rise

UK stocks were trading higher early on in Wednesday's session as US lawmakers moved closer to agreeing on a new stimulus package for the world's biggest economy.Investors also were holding out hope that Britain and the EU could agree on a post-Brexit trade deal before the transition period ends on 1 January.Meaningful progress on either the stimulus or Brexit fronts could help put the markets on t

News in brief: Hikma Pharmaceuticals, Oil, Germany, Bagir, Epwin, Andes Energia

Hikma is not too sickContinuing demand for Hikma Pharmaceuticals' (HIK) injectables and branded businesses and consensus expecting a 30.5% rise in pre-tax profits for 2016 are reasons for investors to stick with the Jordanian drug company. The FTSE 100 member issued a profit warning in November 2015 on lower generic sales. (MD)Oil glut weighsOil prices start 2016 under continuing pressure as the m
Showing 1 to 20 of 24